Nuclear Radiology: Page 60

ECG could replace SPECT MPI for some cardiac patients

By Wayne Forrest

Electrocardiogram (ECG) stress testing alone could be used in place of SPECT myocardial perfusion imaging (MPI) in patients who can exercise at a high capacity, said researchers of a study presented 5 May at the International Conference on Nuclear Cardiology and Cardiac CT in Berlin.

May 5, 2013

Eckert & Ziegler posts Q1 downturn

By AuntMinnieEurope.com staff writers

A drop in radiation therapy sales led to disappointing Q1 results for Eckert & Ziegler, the company reported today.

May 3, 2013

Eckert & Ziegler posts Q1 downturn

By AuntMinnieEurope.com staff writers

A drop in radiation therapy sales led to disappointing Q1 results for Eckert & Ziegler, the company reported today.

May 2, 2013

FLT-PET could help predict outcome in head and neck cancer

By Wayne Forrest

Change in F-18 fluorothymidine (FLT) uptake on PET during early radiotherapy or chemoradiotherapy is a strong indicator of the long-term outcomes of head and neck cancer patients, Dutch researchers report in the April issue of the Journal of Nuclear Medicine.

April 8, 2013

AMIC and GSG form strategic alliance

By AuntMinnieEurope.com staff writers

Medical isotope producer Advanced Medical Isotope (AMIC) is collaborating with Swiss radionuclide manufacturer GSG International to jointly develop medical isotope production technologies and to market and distribute related isotopes, equipment, and services.

March 26, 2013

Mirada signs Copenhagen's Rigshospitalet

By AuntMinnieEurope.com staff writers

Imaging software developer Mirada Medical has received an order from the Rigshospitalet in Copenhagen for its XD3 and RTx software.

March 25, 2013

GE promotes DaTscan study results at AAN meeting

By AuntMinnieEurope.com staff writers

GE Healthcare is touting the results of a randomized study of DaTscan SPECT in adult patients with a diagnosis of possible dementia with Lewy bodies.

March 20, 2013

Piramal's florbetaben PET agent to be reviewed

By AuntMinnieEurope.com staff writers

Piramal Imaging said that the U.S. Food and Drug Administration and the European Medicines Agency have accepted the company's applications for review of its florbetaben investigational PET amyloid imaging agent.

March 20, 2013

IBA results improve in fiscal 2012

By AuntMinnieEurope.com staff writers

Radiopharmaceutical provider Ion Beam Applications (IBA) benefited from increasing market adoption and expanded use of proton therapy treatment, increasing revenues for sales and services by 8.8% during its 2012 fiscal year compared with 2011.

March 18, 2013

'Unfair' regulatory stance on radiotracers poses threat to PET's future

By Becky McCall

VIENNA - Legal and regulatory issues surrounding the production and uses of radiotracers represent a significant threat to PET imaging, a senior luminary told ECR 2013 attendees at Sunday's professional challenges session on the legal matters related to multimodality techniques.

March 10, 2013

Collaboration among specialties enhances prospects of cancer patients

By Becky McCall

VIENNA - Promoting more effective collaboration among radiologists, nuclear medicine physicians, and radiation oncologists to improve imaging and radiotherapy outcomes is a core principle underpinning the lectures in a special focus session on Friday at ECR 2013.

March 7, 2013

Bayer signs Intego PET distribution deal

By AuntMinnieEurope.com staff writers

Bayer HealthCare has signed a distribution agreement for its Medrad Intego PET infusion system with Italian protection technology firm Comecer.

March 4, 2013

Previous Page

Page 60 of 90

Next Page